Physician profile
David Jonathan Shulkin
NPI 1225012883
$1,737,089.21
in general payments reported to CMS, 2019-2025
17 companies · $391K in 2025
The $391K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199K · 2020: $15K · 2021: $88K · 2022: $284K · 2023: $299K · 2024: $460K · 2025: $391K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $985K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $119K · Travel and Lodging: $38K · Entertainment: $5,743 · Food and Beverage: $2,165 · Long Term Medical Supply Or Device Loan: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $984,826.30 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $119,289.07 |
| Travel and Lodging | $38,471.19 |
| Entertainment | $5,742.65 |
| Food and Beverage | $2,164.99 |
| Long Term Medical Supply Or Device Loan | $449.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orasure Technologies INC. | $440,161.82 | 2021-2025 | Inteliswab |
| Philips North America LLC | $377,151.89 | 2019-2022 | |
| 4dmedical USA INC | $258,398.17 | 2023-2024 | Xv Lvas, Ct Lvas, Ct Lvas |
| Vertex Pharmaceuticals Incorporated | $120,000.00 | 2024-2025 | |
| Mimedx Group, INC. | $105,000.00 | 2024-2025 | Bovine Collagen |
| Cala Health, INC. | $105,000.00 | 2024-2025 | Cala Kiq, Cala Trio, Cala Kiq |
| Beckman Coulter, INC. | $90,455.32 | 2024-2025 | Dxh 900 Hematology System |
| Averitas Pharma INC. | $85,161.83 | 2023-2025 | Qutenza |
| Cormedix INC. | $60,000.00 | 2025 | Defencath |
| Potrero Medical, INC. | $32,800.00 | 2023 | |
| Orpyx Medical Technologies INC. | $28,793.22 | 2025 | Orpyx Custom Sensory Insole System |
| Boston Scientific Corporation | $15,000.00 | 2020 | |
| Pfizer INC. | $10,950.63 | 2019 | |
| Apos US Management INC. | $7,500.00 | 2021 | |
| Eko Health, INC. | $449.00 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $233.33 | 2024 | |
| Scilex Pharmaceuticals INC. | $34.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shulkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.